连续性肾脏替代治疗对急性呼吸窘迫综合征患者炎症因子水平和液体管理的影响

Effects of continuous renal replacement therapy on inflammatory factors and fluid management in patients with acute respiratory distress syndrome

急性呼吸窘迫综合征(ARDS)是重症监护病房收治的具有挑战性的危重症之一,连续性肾脏替代治疗(CRRT)技术作为各种危重疾病的重要治疗手段,对ARDS患者救治的影响力也成为关注的热点之一。尽管CRRT技术尚未被纳入指南推荐,但大量研究已经显示CRRT能改善ARDS患者的生存及预后,其中对ARDS炎症因子的清除与液体管理的影响值得重视。

Acute respiratory distress syndrome(ARDS)is one of the challenging critical diseases in pediatric intensive care unit.Continuous renal replacement therapy(CRRT),playing important roles in the treatment of critical illness,has also become one of the hot spots in the treatment of patients with ARDS.Although CRRT technology has not been systematically recommended in the guideline of ARDS managements,numerous studies indicated that CRRT could improve survival and prognosis of ARDS,among which the impact on the clearance of inflammatory factors and fluid management of ARDS deserves attention.